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Previous studies have demonstrated the serologic and T-cell immunogenicity for cattle of a recombinant form
of the apical complex-associated 77-kDa merozite protein ofBabesia bovis, designated Bb-1. The present study
characterizes the immunogenic epitopes of the Bb-1 protein. A series of recombinant truncated fusion proteins
spanning the majority of the Bb-1 protein were expressed in Escherichia coli, and their reactivities with bovine
peripheral blood mononuclear cells and T-cell clones derived from B. bovis-immune cattle and with rabbit
antibodies were determined. Lymphocytes from two immune cattle were preferentially stimulated by the
N-terminal half of the Bb-1 protein (amino acids 23 to 266, termed Bb-lA), localizing the T-cell epitopes to the
Bb-1A portion of the molecule. CD4+ T-cell clones derived by stimulation with the intact Bb-1 fusion protein
were used to identify two T-cell epitopes in the Bb-1A protein, consisting of amino acids SVVLLSAFSGN
VWANEAEVSQVVK and FSDVDKTKSTEKT (residues 23 to 46 and 82 to 94). In contrast, rabbit antiserum
raised against the intact fusion protein reacted only with the C-terminal half of the protein (amino acids 267
to 499, termed Bb-1B), which contained 28 tandem repeats of the tetrapeptide PAEK or PAET. Biological
assays and Northern (RNA) blot analyses for cytokines revealed that following activation with concanavalin A,
T-cell clones reactive against the two Bb-IA epitopes produced interleukin-2, gamma interferon, and tumor
necrosis factors beta and alpha, but not interleukin-4, suggesting that the Bb-1 antigen preferentially stimulates
the Thl subset of CD4+ T cells in cattle. The studies described here report for the first time the
characterization, by cytokine production, of the Thl subset of bovine T cells and show that, as in mice,
protozoal antigens can induce Thl cells in ruminants. This first demonstration of B. bovis-encoded Thl cell
epitopes provides a rationale for incorporation of all or part of the Bb-1 protein into a recombinant vaccine.
Hemoparasitic diseases are endemic in half of the world's
livestock production areas and constitute an important ob-
stacle to the improvement of meat and milk production in
developing nations. It is estimated that over 500 million
cattle are at risk for babesiosis alone (25), and despite
decades of research, there is still no effective, practical, and
safe means of immunizing livestock against this disease.
Babesia bovis can cause a virulent form of babesiosis which
shares many features of human malaria in individuals in-
fected with the related parasite Plasmodium falciparum,
including anemia, toxemia, and adherence of parasitized
erythrocytes to endothelial cells lining the brain and lung
microcapillaries (45). The feasibility of developing a success-
ful babesial vaccine is based on the observations that recov-
ery from acute B. bovis and B. bigemina infection is associ-
ated with development of protective immunity (23) and that
immunization with nonliving parasite extracts can induce
partial protection against subsequent challenge (reviewed in
reference 28). An optimal vaccine would include proteins
with both T- and B-cell epitopes that induce anamnestic
cellular and humoral immunity upon natural exposure to the
parasite (15). However, very little is known about the nature
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of either protective babesial antigens or the immune re-
sponses in cattle that they evoke.
Antibody is undoubtedly important in immunity directed
against extracellular organisms, in which the infectivity of
babesial sporozoites or merozoites might be neutralized by
serum antibodies (18). However, T cells would more prob-
ably play an important role as effector cells in the immune
response directed against the intracellular parasite. Studies
on experimental models of malaria and babesia infections in
mice have shown that CD4+ T cells are required for protec-
tive immunity directed against the intraerythrocytic stage of
infection (2, 8, 9, 19, 31). Although the helper T-cell (Th)
subsets that are involved in protective immunity to these
parasites have not been conclusively identified, it has been
suggested that gamma interferon (IFN--y) and lymphotoxin,
or tumor necrosis factor beta (TNF-,B), produced by both
Thl and CD8+ T cells (13, 26) are important for the resolu-
tion of hemoparasite infections. These cytokines inhibit
parasites by direct toxic effects on the intraerythrocytic
parasite (8), by inhibition of the intrahepatocytic develop-
ment of exoerythrocytic stages (34, 36), and by the activa-
tion of macrophages (1) and neutrophils (20), resulting in
enhanced phagocytosis of parasitized erythrocytes and the
production of TNF-o, which itself has antiparasitic proper-
ties in vivo (40, 41). It should be noted, however, that in
malaria, TNF-a also mediates the cerebral sequestration of
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parasitized erythrocytes (45), exemplifying the intricate bal-
ance between protective immunity and immunopathology.
The central role of T cells in the immune response against
hemoprotozoan parasites, both as helper cells for T-depen-
dent antibody production and as effector cells acting directly
or indirectly on intracellular parasites through the elabora-
tion of cytokines, has prompted an investigation of the
bovine cellular immune response against B. bovis antigens.
In a previous report, we described the induction of CD8+
and CD4+ T cells from B. bovis-immune cattle by a recom-
binant form of the 77-kDa merozoite protein, Bb-1 (42),
which was selected for studies on T-cell immunogenicity for
several reasons. The Bb-1 gene is conserved among New
World and Australian parasites (43) and was predominant
during immunoselection with bovine sera obtained from
cattle naturally infected with B. bovis (44). Affinity-purified
bovine antibody reacted with a 77-kDa merozoite protein on
immunoblots and with the apical end of the merozoites by
immunofluorescence staining (44). Together, these results
suggested a functional importance for the Bb-1 protein and a
logical target for immune intervention and showed that the
Bb-1 protein is immunogenic for naturally infected animals,
i.e., upon natural exposure it could presumably boost mem-
ory T-cell and B-cell responses in cattle vaccinated with this
antigen. In the present study, we have used truncated
recombinant fusion proteins to further characterize the an-
tibody- and T-cell-reactive regions of the Bb-1 protein. Our
results show that the antibody-reactive region is in the
C-terminal half of Bb-1, which contains 28 tandem repeats of
a tetrapeptide, PAEK or PAET, whereas at least two T-cell
epitopes reside in the N-terminal part of the protein. Two Th
clones reactive with these epitopes express the Thl profile of
cytokines (26): interleukin-2 (IL-2), IFN-y, TNF-3, and
TNF-a, but not IL-4, suggesting the preferential induction of
Thl cells by the Bb-1 protein. Furthermore, these studies
have demonstrated for the first time the presence of the Thl
subset of T cells in cattle.
MATERIALS AND METHODS
Experimental cattle. The details of experimental infection
of two cattle with the Mexican isolate of B. bovis were
described in a previous publication (5). Briefly, 2-year-old
crossbred cow C15 was inoculated intravenously with B.
bovis merozoites derived from autologous, infected erythro-
cyte cultures three times over the course of 3 years. Nine-
month-old crossbred cow C97 was infected by infestation
with Boophilus microplus tick larvae infected with the same
Mexican isolate of B. bovis. This animal recovered from
clinical babesiosis after treatment with diaminizine aceturate
and was solidly immune to challenge infection 3 months later
with an intramuscular inoculation of ground-up tick stabi-
late. Peripheral blood mononuclear cells (PBMC) were ob-
tained from immune cattle approximately 1.5 years following
the last challenge infection for proliferation assays and for
establishing T-cell clones. PBMC from animals C15 and C97
expressed the BoLA major histocompatibility complex
(MHC) class I phenotypes w11/w12 and w5/w6, respec-
tively, and apparently expressed different MHC class II
alleles as well, since they were incapable of presenting
antigen to T cells from the reciprocal donor (4).
Construction, expression, and purification of recombinant
Bb-l-GST and truncated Bb-l-GST fusion proteins. Subclon-
ing and expression of the 1,650-bp Bb-1 clone in the pGEX
expression vector was described in a previous publication
(42). Briefly, the Bb-1 gene was excised from recombinant
Agtll and subcloned into pGEXlN (Glutagene; Amrad
Corp. Ltd., Kew, Australia) in frame with the glutathione
S-transferase (GST) gene (39). The recombinant plasmid was
used to transform Escherichia coli DH5a. Polymerase chain
reaction (PCR) was used to produce recombinant proteins
representing the N-terminal (Bb-1A) and C-terminal (Bb-1B)
halves of Bb-1 and to produce a nested set of fusion proteins
truncated from the amino-terminal end of Bb-1A (Bb-1C,
Bb-1D, and Bb-1E). To accomplish this, primers based on
the nucleotide sequence (43) were designed so that the DNA
encoding the Bb-1 mutant proteins could be cloned as EcoRI
fragments in the fusion vector pGEX2T (Pharmacia, Piscat-
away, N.J.) in frame with the gene encoding GST. PCRs
were carried out by using a thermocycler and kit (Perkin-
Elmer Corp., Norwalk, Conn.) with 100-,ul reaction volumes
(containing 1.25 mM nucleotide mix, 2.5 U of Taq DNA
polymerase, 20 pM of each primer, 20 ng of Bb-1 template
DNA, and PCR buffer containing 2 mM Mg2+) for 35 cycles
with a denaturation temperature of 94°C for 1 min, an
annealing temperature of 60°C for 1 min, and an extension
temperature of 72°C for 1 min with a 15-s autoextension
setting. The amplified gene products were electrophoresed
on a 1% agarose gel, electroeluted, purified on a NACS 52
PREPAC column (GIBCO BRL, Gaithersburg, Md.), and
ligated into the pGEX2T fusion vector for expression in E.
coli.
To obtain a nested set of deletion mutants of the Bb-1A
fragment, which were truncated from the carboxy end of the
protein, exonuclease III and mung bean nuclease digestions
proceeding from the 3' ends of the cDNAs were performed
by using the Erase-a-Base kit (Promega, Madison, Wis.). We
selected a series of truncated cDNAs which were expressed
as fusion proteins designated Bb-1A-GST clone 10, clone
6C, clone 2D, and clone 2B. The resulting deletion mutants
were then ligated into pGEX2T, and the DNA was trans-
fected into E. coli DH5a. Recombinant fusion proteins were
induced for 90 min with 5 mM isopropyl-j-D-thiogalactopy-
ranoside (IPTG; Sigma Chemical Co., St. Louis, Mo.). Cells
were centrifuged for 15 min at 5,000 x g; resuspended in
1/100 the starting volume in phosphate-buffered saline (PBS;
pH 7.2) containing 1 mM phenylmethylsulfonyl fluoride, 50
mM EDTA, and 1% Triton X-100; and lysed by sonication.
To affinity purify the fusion proteins, we centrifuged the
lysates for 5 min at 11,000 x g and incubated the superna-
tants for 1 h at room temperature with a 50% suspension of
glutathione-agarose beads (Sigma) prepared as specified by
the manufacturer. Bound fusion protein was eluted from the
beads with 25 mM reduced glutathione (Sigma) in 50 mM
Tris-HCl buffer (pH 8.5) and concentrated with a Cen-
triprep-10 concentrator (Amicon, Beverly, Mass.). GST was
prepared in the same manner from E. coli transformed with
pGEX2T.
Sequence analysis. Peptide sequences encoded by trun-
cated Bb-1 genes were determined from the DNA sequence
of each clone. Nucleotide sequence analysis of the 3' ends of
truncated Bb-1 genes was performed by directly sequencing
duplex DNA in the pGEX2T vector by the dideoxy sequenc-
ing method of Sanger et al. (32). Sequenase enzyme (U.S.
Biochemical Corp., Cleveland, Ohio) and a primer comple-
mentary to residues 1212 to 1233 of the pGEX2T vector were
used in the reactions. The amino acid sequence of the B.
bovis 77-kDa Bb-1 protein was analyzed for potential T-cell
epitopes by using the computer program TSites (11), kindly
provided by Vidal de la Cruz, Medlmmune, Inc., Gaithers-
burg, Md. This program predicts amphipathic regions of the
sequence characteristic of structures that might form stable
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ot-helical configurations, using the AMPHI algorithm with
overlapping blocks of 11 amino acids (24), and simulta-
neously identifies the structural T-cell motif described by
Rothbard and Taylor (29) as well as I-Ad- and I-Ed-binding
motifs identified by Sette et al. (38).
SDS-PAGE and immunoblot analysis of recombinant Bb-1-
GST fusion proteins. Intact Bb-1-GST (20 ,ug per lane), GST
(10 ,ug per lane), and deletion fusion proteins Bb-1A (10 ,ug
per lane), clone 10 (20 ,ug per lane), clone 6C (15 ,ug per
lane), Bb-1C (10 ,ug per lane), Bb-1D (10 pRg per lane), and
Bb-1E (10 ,ug per lane) were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(12% polyacrylamide) and stained with Coomassie blue.
Low-molecular-mass standards (Bio-Rad, Richmond, Calif.)
were included. To analyze the serologic reactivity of a
monospecific rabbit antiserum raised against Bb-1-GST (42)
for the Bb-1 fusion proteins, 10 ,g of Bb-1B-GST, Bb-lA-
GST, intact Bb-1-GST, or GST proteins were electrophore-
sed in a 12% polyacrylamide gel and transferred to nitrocel-
lulose. Hyperimmune rabbit antiserum was preabsorbed
with E. coli lysate and GST-agarose beads, diluted 1:560 in
PBS, and used to develop the immunoblot as described
previously (42) with alkaline phosphatase-conjugated goat
anti-rabbit immunoglobulin G heavy and light chains
(Kirkegaard & Perry Laboratories, Gaithersburg, Md.) and
chromogenic substrates Nitro Blue Tetrazolium and 5-bro-
mo-4-chloro-3-indolyl phosphate (Sigma).
T-cell clones. Three CD4+ T-cell clones were established
previously (42) from animal C97 by stimulating PBMC in
vitro with recombinant Bb-1-GST and limited-dilution clon-
ing of antigen-activated T cells in the presence of bovine
T-cell growth factor (TCGF), Bb-1-GST, and irradiated
(3,000 rad) PBMC as a source of antigen-presenting cells
(APC). The clones, designated C97.1B10, C97.1C8, and
C97.1D1, proliferated in a dose-dependent manner to Bb-1-
GST but not to GST (42). The T-cell clones were maintained
for several months in 1.5-ml cultures in 24-well plates
(Costar, Cambridge, Mass.) by weekly stimulation with 25
,ug of Bb-1-GST per ml, APC, and 10% TCGF. Cells were
also cryopreserved in a mixture of 10% dimethyl sulfoxide in
fetal bovine serum.
Lymphocyte proliferation assays. PBMC were obtained
from B. bovis-immune animals C15 and C97 for proliferation
assays, which were performed in triplicate wells of 96-well
half-area plates (Costar) for 6 days as described previously
(42) with the following modifications. Briefly, 2 x 105 PBMC
were cultured in a total volume of 100 RI of complete RPMI
1640 medium (5) containing 5 to 25 ,ug of recombinant
Bb-1-GST, Bb-1A-GST, Bb-1B-GST, or GST per ml. The
cells were radiolabeled for the last 4 h of culture with
[1251I]iododeoxyuridine (ICN Radiochemicals, Inc., Costa
Mesa, Calif.) and harvested onto glass filters, and radioac-
tivity was counted in a gamma counter. T-cell clones were
assayed 6 to 7 days after the last stimulation with antigen and
APC for proliferation against recombinant fusion proteins in
duplicate wells of 96-well half-area plates essentially as
described previously (42). Briefly, 3 x 104 T cells were
cultured for 3 days in a total volume of 100 RI in complete
medium containing 0.4 to 50 ,ug of antigen per ml and 2 x 105
irradiated autologous or MHC-mismatched APC. The cells
were radiolabeled during the last 4 h of culture with
[1251]iododeoxyuridine, harvested, and counted. In one ex-
periment, a monoclonal antibody, IL-A21 (kindly provided
by John Ellis, University of Wyoming), which reacts with
bovine MHC class II antigens was added at a final concen-
tration of 10 ,ug/ml to the T cells in the presence of either
antigen or IL-2. Results are presented as the mean cpm and
one standard deviation of replicate cultures.
Stimulation of T-cell clones and biological assays for cyto-
kine production. T cells obtained 6 or 7 days after the last
stimulation with antigen plus APC were washed in complete
medium and cultured for 17 h at a concentration of 2 x 106
cells per ml of complete medium containing S p,g of con-
canavalin A (ConA; Sigma) per ml in the absence of APC.
Supernatants were harvested by centrifugation and stored at
-80°C. IFN activity in culture supernatants was measured in
a microtiter cytopathic effect assay with vesicular stomatitis
virus and Madin-Darby bovine kidney (MDBK) cells as
described previously (6). MDBK cell survival was evaluated
by the 4-h uptake of MTT dye in the cells (16). IFN titers
were compared with a human recombinant IFN-a2 reference
reagent (no. GxaOl-901-535; National Institutes of Health,
Bethesda, Md.) with a reported activity of 3.95 log1o IU/ml,
which in our assay had a titer of 3.35 + 0.18 log1o IU/ml.
ConA alone had no IFN activity.
To measure TNF-a and TNF-1 produced by activated T
cells, a TNF-sensitive WEHI-164 subline from Edward
Lattime, Memorial Sloan-Kettering, New York, N.Y., was
incubated with culture supernatants in a 48-h assay (30).
Cytotoxicity was determined by the MTT dye reduction
assay. TNF titers in the supernatants were compared with a
standard human recombinant TNF-ao (Upstate Biotechnol-
ogy Inc., Lake Placid, N.Y.), which had a reported activity
of 6 log1o U/ml and in our assay had a titer of 5.92 ± 0.15
log1o U/ml. ConA alone had no TNF activity.
A CD8+, cloned, IL-2-dependent bovine T-cell line, des-
ignated G1.G3, was used to measure IL-2/IL-4 activity in
culture supernatants. Residual ConA was removed from
supernatants harvested from the T-cell cultures by addition
of 20 p,g of methyl-a-D-mannopyranoside (Sigma) per ml and
subsequent centrifugation and filter sterilization. These and
a control sample consisting of complete medium containing 5
,ug of ConA per ml treated in the same manner with
methyl-a-D-mannopyranoside were diluted 1/2 to 1/256 in
complete medium and added to duplicate wells of G1.G3
cells which had been distributed at a density of 3 x 104 cells
per well in 96-well half-area microtiter plates. In all assays,
recombinant human IL-2 (Boehringer-Mannheim Biochemi-
cals, Indianapolis, Ind.) was serially diluted from 100 to <1
U/ml for use as a reference standard. The cells were cultured
for 48 to 72 h and were radiolabeled with 25 ,uCi of[1251]iododeoxyuridine during the last 4 h. A semiquantita-
tive estimate of IL-2/IL-4 activity in the culture supernatants
was obtained by comparison with a standard curve of human
recombinant IL-2.
Northern blot analysis. Total RNA was obtained from
unstimulated MDBK cells or from PBMC and T-cell clones
that had been cultured for 8 or 18 h with ConA by using 2 ml
of RNAzol B (Biotecx Laboratories, Inc., Houston, Tex.)
per 107 cells as specified by the manufacturer. RNA (30 jig)
was subjected to electrophoresis in a formaldehyde-morpho-
linepropanesulfonic acid (MOPS)-1.6% agarose gel, trans-
ferred to GeneScreen nylon filters (DuPont NEN, Boston,
Mass.), and hybridized with the following cDNA probes.
The IL-2 cDNA probe consisted of a 0.79-kb EcoRI frag-
ment of the bovine IL-2 cDNA (27) and was a generous gift
from Raymond Reeves, Washington State University. The
IL-4 cDNA probe consisted of a 0.33-kb HindIII-XbaI
fragment of bovine IL-4 cDNA (17). The actin cDNA probe
consisted of a 1.0-kb EcoRI fragment of bovine actin cDNA
(10) and was kindly provided by Angelika Ehrfeld, Max
Planck Institute for Immunology, Freiburg, Germany. The
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TNF-a cDNA probe consisted of a 0.6-kb EcoRI-NsiI frag-
ment of bovine TNF-ao cDNA (14). The IFN--y probe con-
sisted of a 0.5-kb XbaI-DraI fragment of bovine IFN--y
cDNA. Both TNF-ot and IFN--y probes were a generous gift
from Arjun Singh, Genentech, South San Francisco, Calif.
The TNF-13 cDNA probe consisted of a 0.71-kb KpnI-HincII
fragment of the murine TNF-p cDNA (21) and was a
generous gift from Nancy Ruddle, Yale University Medical
School. The cDNAs were labeled with 32P by the random
primer method with a kit from Boehringer-Mannheim, yield-
ing probes with a specific activity of 1 x 109 to 2 x 109
cpm/,ug. Filters were prehybridized for 24 h at 42°C in a
solution of 50% formamide in hybridization buffer (5x SSC
[lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate], lx
Denhardt's reagent, 0.5% SDS) and hybridized with the
radiolabeled probes (5 x 106 cpm of probe per ml of
hybridization buffer) for 48 h under the same conditions. The
filters were washed twice at room temperature for 5 min with
2x SSC-0.5% SDS and then either twice at 50°C for 30 min
with 0.2x SSC-0.5% SDS when using IFN--y, TNF-1,
TNF-ao, and actin probes or once at 50°C for 15 to 30 min
with 0.5x SSC-0.5% SDS when using the IL-2 and IL-4
probes. The filters were then exposed to Hyperfilm (Amer-
sham Corp., Arlington Heights, Ill.) at -80°C. The approx-
imate sizes of the transcripts in kilobases were determined
from nucleic acid molecular size standards (0.24- to 9.5-kb
RNA ladder; GIBCO BRL) that were electrophoresed,
transferred to nylon, and stained with methylene blue.
Nucleotide sequence accession number. The nucleotide and
amino acid sequences reported in this paper have been
submitted to the GenBank data base (accession number
M99575).
RESULTS
Expression of Bb-l-GST deletion fusion proteins. The
1,650-bp Bb-1 gene fragment was previously subcloned and
expressed by using the pGEX expression vector (42). This
approach permits the production of large amounts of recom-
binant fusion protein fused to GST and the ready purification
of the recombinant protein through the affinity of GST for its
substrate (glutathione-coated beads). The cloned gene en-
codes 59 kDa of the 77-kDa native protein observed by
SDS-PAGE (42, 44). The nucleotide sequence of the Bb-1
gene will be reported elsewhere (43). The predicted amino
acid sequence of the Bb-1 gene is shown in Fig. 1A. The
sequence was found to be unique, with the exception of 28
tandem repeats of a tetrapeptide PAEK or PAET in the
carboxy-terminal half of the protein (residues 316 to 427). A
second distinctive characteristic of the protein is the pres-
ence of a polyserine tract (residues 288 to 300) flanked by
negatively charged residues. To define the location of anti-
body- and T-cell-reactive regions, the Bb-1 gene was trun-
cated and nested sets of recombinant proteins were pro-
duced for proliferation and immunoblot assays (Fig. 1B).
The relative sizes of the intact Bb-1-GST and Bb-1A-GST
and truncated Bb-1A-GST fusion proteins were determined
by SDS-PAGE and are shown in Fig. 2. As noted previously
(42), the intact Bb-1 fusion protein migrates as a faintly
visible band of approximately 72 kDa and degradation prod-
ucts of approximately 28 to 30 kDa (lane A), whereas fusion
proteins Bb-1A (lane B), Bb-1C (lane C), Bb-1D (lane D),
and Bb-1E (lane E), ranging in apparent molecular mass
from 54 to 46 kDa, are relatively stable. Bb-1A clone 2B has
an apparent molecular mass of 50 kDa (not shown), clone 2D
has an apparent molecular mass of 43 kDa (not shown),
clone 6C (lane F) has an apparent molecular mass of 38 kDa,
and clone 10 (lane G) has an apparent molecular mass of 33
kDa. The last two fusion proteins contain smaller degrada-
tion products. Recombinant GST (lane H) is also shown.
Antibody-reactive epitopes on Bb-1. Hyperimmune rabbit
antiserum raised against Bb-1-GST was previously shown to
react on immunoblots with both recombinant Bb-1-GST and
the native 77-kDa protein in crude extracts of B. bovis
merozoites (42). To more precisely define the antibody-
binding epitopes, we reacted hyperimmune rabbit antiserum
on immunoblots with the two halves of the Bb-1 protein,
Bb-1A and Bb-1B (Fig. 3), following extensive absorption of
GST reactivity with GST-coated agarose beads. Interest-
ingly, the antiserum recognized only fusion proteins contain-
ing sequences in the carboxy-terminal half of the protein,
revealing an intense reaction with Bb-1B-GST (lane A), a
fainter reaction with Bb-1-GST (lane C), and no binding to
either Bb-1A-GST (lane B) or GST (lane D).
Proliferative responses of PBMC from B. bovis-immune
cattle to Bb-1A and Bb-1B fusion proteins. Previous experi-
ments had documented that PBMC from two immune cattle
(C15 and C97) but not a normal control animal proliferated in
response to Bb-1-GST, with little or no response to recom-
binant GST (42). To localize the T-cell-reactive epitopes in
the Bb-1 protein, we repeated the proliferation assay with
recombinant Bb-IA and Bb-1B fusion proteins in addition to
those already tested (Fig. 4). The results confirmed our
previous finding and further showed that B. bovis-immune
PBMC from animals C97 (Fig. 4A) and C15 (Fig. 4B)
responded at least as well to Bb-1A-GST as to intact
Bb-l-GST, whereas the response to Bb-1B-GST was less
than or equal to the response to the control GST protein.
PBMC from two nonimmune cattle were not stimulated by
either of these fusion proteins or GST (data not shown).
T-cell epitope mapping with Bb-l-specific T-cell clones.
Three Bb-l-specific CD4+ T-cell clones derived from animal
C97 were obtained by limited-dilution cloning in the pres-
ence of intact Bb-l-GST (42). The results of assays with two
of the Th clones (C97.1C8 and C97.1B10) are presented,
since the third clone (C97.1D1) had the same pattern of
reactivity as clone C97.1B10. To further define the epitopes
recognized by these Th clones, we measured proliferation
against the Bb-1A and Bb-1B fusion proteins. Both clones
responded to Bb-1A-GST in a dose-dependent manner but
not to either Bb-1B-GST or GST, as shown in Fig. 5. The
response to Bb-1A-GST was shown to be MHC restricted,
since APC from MHC-mismatched animal C15 could not
present antigen to the two clones, whereas the proliferation
induced by TCGF in the presence of mismatched APC was
not abolished (Fig. 6). A monoclonal antibody, IL-A21, that
reacts specifically with bovine MHC class II determinants
completely blocked the proliferation to antigen but did not
inhibit the response to IL-2 (data not presented), demon-
strating that the Th clones react to antigen in an MHC
class-II restricted manner.
A set of nested deletion fusion mutants of Bb-1A were
produced by exonuclease III and mung bean nuclease diges-
tion from the 3' end of the DNA, and some of these mutants
were sequenced (Fig. 1B). Expressed fusion proteins of the
Bb-1A subclones were then assayed for the ability to stim-
ulate the Th clones. Interestingly, the two T-cell clones
responded in a differential manner to expressed proteins of
Bb-1A clones 2B, 2D, 6C, and 10 (Table 1). T-cell clone
C97.1C8 responded in a dose-dependent manner to all fusion
proteins except for the smallest (clone 10), against which no
proliferation was observed at any concentration of antigen
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5 10 15 20 25 30 35 40 45 50 55 60 65 70 75
VSGHLVCKSGFGLGV MJVL.AFGVXRESVRGSVNGWWPTKGEYDVDPEMM=XDVYDD
80 85 90 95 100 105 110 115 120 125 130 135 140 145 150
YRrYNGESnDVDRTSTEKTSLGDIFMKLGPKKCMNLRVKDVDVDMQRANRRLATILQHITDHTPKSPMFAVSENI
***********
155 160 165 170 175 180 185 190 195 200 205 210 215 220 225
VKALNKQHTIELPKALAQQLCQFDAKAMKTCESRQFKDAFSTFFADFIADVLLGYSPMSEHMGVRCKAFGQIKKH
230 235 240 245 250 255 260 265 270 275 280 285 290 295 300
VLLSLNGIEDLDKESCVNVTQPAIPTIPEEPVAEEPSDVTVTAPEECEEEIVINPEEENKPDSSSSSSSSSSSSS
305 310 315 320 325 330 335 340 345 350 355 360 365 370 375
ESDSDEEDREPVVEEPAEKPAEKPAEKPAEKPAETPAETPAEKPAEKPAEKPAEKPAEKPAEKPAEKPAETPAET
380 385 390 395 400 405 410 415 420 425 430 435 440 445 450
PAETPAEKPAETPAETPAETPAETPAETPAETPAETPAETPAETPAEKPAEKPASRPCYGGRKGEEVVVLQTTST
455 460 465 470 475 480 485 490 495 500 505 510 515 520 525
KQTPLKELPVVKGPSTNRLWHENVDIDMPVVQKRLSTILGYVTNYDPKHPFFAVSENIVKVLNKSCDFALPEDLA
530 535 540 545
VZLSSIESGKIFGYEWEVFT
B.
Sb-lA C1.10
Sb-lA cl.6C
Bb-lA cl.2D
Sb-lA I
Bb-1 I
Sb-lE
Sb-lD I
Sb-lC I
Sb-lB
(23-70)(23-94)(23-174)] (23-266)
(23-545)
a1 (82-266)3 (59-266)
a1 (48-266)
I (267-499)
100 200 300 400 500
amino acids
FIG. 1. Analysis of Bb-1 and truncated fusion proteins. (A) Predicted amino acid sequence of the Bb-1 protein encoded by 1,650 bp of the
Bb-1 gene. Experimentally identified T-cell epitopes are underlined and indicated by asterisks. (B) Graphic representation of Bb-1 and
truncated fusion proteins, encoded by Bb-1 subfragments indicated at the left of the figure. Subclones Bb-1A, Bb-1B, Bb-1C, Bb-1D, and
Bb-1E were obtained by PCR amplification of specific residues. Bb-1A subclones 10, 6C, and 2D were obtained by exonuclease III and mung
bean nuclease digestion of the Bb-1A DNA from the 3' end. The amino acid residues included in each subclone are indicated in parentheses
on the right of the figure.
ranging from 0.4 to 50 ,g of protein per ml. In contrast,
T-cell clone C97.1B1O proliferated against all fusion pro-
teins, including the smallest (clone 10). These data show that
clone C97.1C8 recognized an epitope within residues 71 to
94, whereas clone C97.1B10 recognized an epitope within
residues 23 to 70.
To further define these two epitopes, we used PCR to
create additional fusion proteins Bb-1C, Bb-1D, and Bb-1E,
which contained sequences within these T-cell-reactive re-
gions (Fig. 1B). Clone C97.1C8 recognized all three of these
proteins, whereas clone C97.1B10 did not respond to any of
them (Table 2), thus mapping the T-cell epitopes within
amino acids 23 to 46 (clone C97.1B10) and 82 to 94 (clone
C97.1C8), as depicted in Fig. 1A. Both of these sequences
contained regions predicted by the AMPHI algorithm (24) to
form amphipathic helices that are antigenic T-cell sites (data
not presented).
Analysis of cytokines produced by the Th clones. Biological
assays to measure bovine TNF-ot (6), TNF-P (6), IFN--y (6),
and IL-2 and IL-4 activities were performed. The CD8+,
IL-2-dependent cell line, G1.G3, expressed both IL-2 and
IL-4 mRNA upon ConA activation and proliferated in re-
sponse to delectinated supernatants from ConA-stimulated
G1.G3 cells (3). The cell line also responded to recombinant
human IL-2. We have been unable to detect stimulation of
bovine lymphocytes with recombinant human IL-4, and
recombinant bovine IL-4 is unavailable, so the ability of
these cells to respond to IL-4 has not been confirmed. These
three bioassays showed that supernatants of T-cell clone
C97.1C8 produced detectable levels of all three activities
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FIG. 2. Analysis of the relative molecular masses of the nested
deletion Bb-1 fusion proteins by SDS-PAGE. All recombinant
proteins, with the exception of GST, were babesial proteins fused
with GST. Lanes: A, Bb-1; B, Bb-1A; C, Bb-1C; D, Bb-1D; E,
Bb-1E; F, Bb-1A subclone 10; G, Bb-1A subclone 6C; H, GST. The
relative mobilities (M) of the molecular mass standards are indicated
on the left (in kilodaltons).
whereas clone C97.1B10 produced detectable levels of IFN
and TNF-afJNF-, following ConA activation (Table 3).
Because the assays do not distinguish IL-2 and IL-4 or
TNF-a and TNF-P activities, Northern blot analysis of total
RNA extracted from ConA-activated T-cell clones, ConA-
stimulated PBMC (positive control), or MDBK cells (nega-
tive control) was performed with cDNA probes for bovine
IL-2, IL-4, IFN--y, and TNF-a and murine TNF-1 (Fig. 7).
The blot probed with IL-4 was stripped and rehybridized
with the bovine actin probe as a positive control to semi-
quantify RNA on the blot. IFN-,y mRNA was present in both
clones stimulated for 8 or 18 h with ConA. IL-2 mRNA was
detectable only in cells stimulated for 8 h, whereas IL-4
mRNA was never detected in the T-cell clones. Both Th
clones expressed TNF-3 and TNF-a mRNAs. As expected,
the intensities of the mRNA bands corresponded to the
relative amounts of cytokines detected in the culture super-
natants (Table 3), with clone C97.1C8 having stronger sig-
nals on Northern blots and higher levels of all three cytokine
activities. In contrast to the results with the Th clones,
PBMC activated for 18 h with ConA expressed detectable
levels of IL-2, IL-4, IFN--y, and TNF-P but not TNF-a
mRNA and MDBK cells never expressed any of the cyto-
kine mRNAs. The failure to detect IL-4 mRNA in the two
A B C D
97 -
66- _
45 -
31-
21-
FIG. 3. Antibody-reactive epitopes localized to the carboxy-
terminal half of Bb-1 by immunoblot analysis of recombinant
Bb-l-GST fusion proteins. Hyperimmune rabbit antiserum exten-
sively adsorbed of GST reactivity was used to probe fusion proteins
or GST following electrophoresis of 10 ,ug of protein per lane and
transfer to nitrocellulose. Lanes: A, Bb-1B-GST; B, Bb-1A-GST;
C, Bb-1-GST; D, GST. The relative mobilities of the molecular
mass standards are indicated on the left (in kilodaltons).
w
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B.
Bb-i -GST
o
+ < ~~~~~~Bb.18B-GST0
0 1 0 20 30
PROTEIN CONCENTRATION (pG/ML)
FIG. 4. Proliferative responses of PBMC against recombinant
Bb-1 fusion proteins or GST. PBMC from B. bovis-immune cattle
C97 (A) and C15 (B) were stimulated for 6 days with the indicated
concentrations of antigen. Error bars indicate standard deviations.
T-cell clones was not caused by insufficient RNA on the blot,
since this blot reprobed with bovine actin revealed intense
signals. Furthermore, exposure of blots for up to 10 days
failed to reveal any IL-4 mRNA signals in the T-cell clones
(data not shown). These results show that the two Bb-1-
specific T-cell clones described in this study belong to the
Thl subset of helper T cells.
DISCUSSION
T-cell recognition of protozoal antigens is believed to be
associated with protective immunity. In malaria, both CD4+
and CD8+ T cells are important for resolving infection. In
CLONE C971C8 CLONE C97.1B10
z 40 40
i
CW 30 30
:) 20 200
o 10 10
0 0 .
0 10 20 30 40 50 60 0 10 20 30 40 50 60
PROTEIN CONCENTRATION (MG/ML) PROTEIN CONCENTRATION (gG/ML)
FIG. 5. T-cell-reactive epitopes localized to the amino-terminal
half of the Bb-1 protein by analysis of proliferative responses of
Bb-l-specific T-cell clones. T cells were stimulated with the indi-
cated concentrations of Bb-lA-GST (A), Bb-1B-GST (0), or GST
(A) in a 3-day proliferation assay. Error bars that indicate standard
deviations were included but may not be apparent because of the
small values.
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FIG. 6. Requirement for autologous APC by Bb-lA-specific T-cell clones for antigen-induced proliferation. T-cell clones were stimulated
for 3 days with bovine TCGF (5%) or antigen (25 ,ug of either GST or Bb-1A-GST per ml) in the presence of either autologous C97 APC or
MHC-mismatched C15 APC. Error bars indicate standard deviations.
experimental leishmania infection, Thl cells conferred pro-
tection whereas Th2 cells, which produce IL-4, exacerbated
the disease (37). However, in bovine babesiosis, neither the
type of T-cell response nor the protective epitopes of babe-
sial parasite antigens have been identified. Because T cells,
through the elaboration of cytokines, are central to both
humoral and cell-mediated immune responses and are criti-
cal for activating macrophages, we have examined in detail
the T-cell response to the B. bovis-encoded recombinant
Bb-1 protein, a potential vaccine antigen.
In this study, truncated recombinant fusion proteins and
T-cell clones were used to identify T-cell-reactive epitopes
on Bb-1. Preferential stimulation of B. bovis-immune PBMC
by Bb-1A suggested the presence of T-cell epitopes on the
N-terminal half of the protein. This was confirmed by studies
showing that Th clones induced by stimulation with intact
Bb-1-GST reacted with Bb-1A but not Bb-1B fusion pro-
teins. In addition, attempts to generate T-cell lines from
animals C97 and C15 by repeated stimulation with the Bb-1B
fusion protein were unsuccessful, confirming that this part of
the molecule is less immunogenic for T cells. Two T-cell
epitopes on Bb-1A were localized by examining the prolif-
eration of T-cell clones against fusion proteins truncated
from either the amino- or carboxy-terminal end of Bb-1A.
The T-cell-reactive regions are located within amino acids 23
to 46 (SVVLLSAFSGNVWANEAEVSQVVK) and 82 to 94
TABLE 1. Proliferative responses of Bb-l-specific Th clones
against Bb-1A fusion proteins truncated from the C-terminal end
Radioactivity (mean cpm t SD)
Fusion protein incorporated by Th cloneb:
(approx mol wt)a
C97.1C8 C97.lB10
Medium 363 2 385 12
GST (26,000) 386 25 470 24
Bb-1A-GST (54,000) 20,401 1,639 25,626 448
Clone 2B (50,000) 63,071 4,709 21,895 946
Clone 2D (43,000) 27,347 4,718 9,244 + 673
Clone 6C (38,000) 84,130 + 1,830 27,471 + 379
Clone 10 (33,000) 492 1 26,830 + 386
a A final concentration of 25 ,ug of protein per ml was used. The estimated
molecular weights of the fusion proteins analyzed by SDS-PAGE are indi-
cated in parentheses.
b Results are presented as the mean cpm + standard deviation (SD) of
duplicate cultures of T cells stimulated with antigen for 3 days.
(FSDVDKTKSTEKT). Both regions contain motifs capable
of forming a-helical structures predicted by the AMPHI
algorithm (24), but none of the other algorithms were useful
in predicting T-cell epitopes.
Both Bb-1-specific T-cell clones appear to belong to the
Thl subset, since they expressed IL-2, IFN--y, and TNF-P
but not IL-4 mRNA (26). Importantly, the clones also
secreted these cytokines, as determined by biological assays
and the observation that the clones proliferated in response
to antigen in the absence of exogenous IL-2 or IL-4. To our
knowledge, this is the first report of bovine T-cell clones that
can be classified as Thl cells. Others have reported the
expression of both IL-2 and IL-4 mRNA in bovine T-cell
clones specific for Oesophagostosum radiatum (7), and we
have observed that the majority of CD4+ T-cell clones
reactive with undefined B. bovis merozoite antigens (6)
expressed IL-2, IL-4, and IFN--y mRNA (3), indicating the
induction of the ThO (12) subset of T cells by these different
cattle parasites. It has been suggested that the conditions
under which T cells are selected in vitro before cloning can
TABLE 2. Fine-specificity mapping of Th epitopes on Bb-1A by
induction of proliferative responses of Bb-l-specific Th clones
against Bb-1A fusion proteins truncated from the N-terminal end
Radioactivity (mean cpm ± SD)
Fusion Concn incorporated by Th cloneb:
proteina (Lg/ml)
C97.1C8 C97.1B10
Medium 295 ± 91 896 ± 66
GST 10 321 ± 75 880 ± 156
50 251 ± 3 1,188 ± 272
Bb-1A-GST, 10 8,138 ± 476 5,571 ± 917
clone 6C
50 38,134 ± 781 9,182 ± 34
Bb-1C-GST 10 18,826 ± 1,068 1,821 ± 139
50 23,258 + 1,280 650 ± 55
Bb-1D-GST 10 9,713 + 1,479 1,448 ± 460
50 30,731 ± 156 820 ± 173
Bb-1E-GST 10 7,579 ± 135 1,315 ± 24
50 23,189 ± 303 2,143 ± 67
a Recombinant GST and GST fusion proteins Bb-1A clone 6C, Bb-1C,
Bb-1D, and Bb-1E were tested at final concentrations of 10 and 50 ,ug of
protein per ml for the capacity to stimulate two Th clones.
b Results are presented as the mean cpm ± standard deviation (SD) of
duplicate cultures of T cells stimulated with antigen for 3 days.
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TABLE 3. Production of cytokines by Bb-1-specific Th clones
stimulated with ConAa
Cytokine activity (U/ml)
Th clone
IL-2/IL-4 IFN TNF
C97.1C8 8-24 45-57 32
C97.1B10 <2 9 6
a T cells were stimulated with 5 pLg of ConA per ml for 17 h, and the
supernatants were tested for the indicated cytokines.
bias the cytokines produced. Maggi et al. (22) recently
demonstrated that when human purified protein derivative-
specific T-cell lines were cultured with IL-2 and antigen, T
cells cloned from the cell lines produced the Thl pattern of
cytokines: IL-2 and IFN--y but not IL-4 or IL-5. However,
addition of IL-4 to purified protein derivative-specific cell
lines resulted in the development of purified protein deriva-
tive-specific T-cell clones able to produce an unrestricted or
ThO pattern of cytokines: IL-2, IFN--y, IL-4, and IL-5. In our
experiments, T cells were stimulated with Bb-1 antigen in
en C
(I) 0D
co CO c )
Fn- -
0D
kB 2 C) )
1.0
.6
1.5
1.7
1.4
W-
L-2
IL -4
TNF- P
TNF- cx
IFN-
2.1 - Actin
FIG. 7. Identification of cytokine mRNA expression in Bb-1A-
specific helper T-cell clones by Northern blot analysis. RNA was
obtained from the following cells: PBMC activated for 18 h with
ConA (ConA blasts), MDBK cells, and T-cell clones C97.1C8 and
C97.1B10 activated for 8 h with ConA. Total cellular RNA (30 ,ug)
derived from the indicated cells was electrophoresed in a 1.6%
agarose gel, transferred to nylon filters, and probed with the
radiolabeled cDNA probes (see Materials and Methods) indicated
on the right. Filters were exposed for the following periods: IL-2, 7
days; IL-4, 4 'ays; TNF-0, 7 days; TNF-a, 8 h; IFN-y, 4 to 5 h;
actin, 1 h. The approximate sizes (in kilobases) of the indicated
cytokine transcripts are shown on the left.
the absence of exogenous growth factors prior to cloning and
were cloned in the presence of bovine TCGF that contains
both IL-2 and IL-4. The absence of IL-4 expression by the
Bb-1-specific T-cell clones therefore indicates that the Bb-1
protein preferentially induced the proliferation of Thl cells
in the uncloned T-cell lines. The production of IL-2, IFN--y,
TNF-,B, and TNF-a by Bb-1-specific T cells provides a
rational basis for hypothesizing that this antigen may evoke
a protective immune response against Babesia infection in
cattle, since these cytokines and Thl cells have been shown
to be associated with the resolution of related intracellular
protozoal infections.
Although bovine B-cell epitope-mapping studies have not
yet been performed, results with rabbit anti-Bb-1 serum
suggest that conformation-independent antibody-binding
epitopes reside on the Bb-1B half of the protein, which
contains 28 tandem repeats of tetrapeptide PAEK or PAET.
On the basis of the immunogenicity of this type of repeating
element in other proteins of protozoal parasites (33), the
tetrapeptide repeats probably constitute the antibody-bind-
ing region. It has been proposed that in malaria infections,
the repeat regions function to stimulate nonprotective T-in-
dependent antibody responses (immunological smoke-
screen), which are inferior to T-dependent ones since they
do not usually undergo affinity maturation or involve T- and
B-cell memory (33, 35). Furthermore, the repeating epitopes
may suppress the development of antibody responses to
adjacent (and possibly protective) regions of the protein (33),
as suggested by our data showing a selective antibody
response to Bb-1B in Bb-l-immunized rabbits. Recombinant
proteins either containing or lacking the repetitive sequences
will be used in epitope-mapping studies to determine
whether the tetrapeptide is a target of the antibody response.
In conclusion, the Bb-1A region of the 77-kDa merozoite
protein has properties consistent with the induction of a
protective helper T-cell response important for the design of
a subunit protozoal vaccine. Further experiments are needed
to define how restricted the response is with respect to MHC
class II expression, to map B-cell epitopes in cattle, to
identify the isotype of the antibody induced by the Th cell
clones, and to determine whether anti-Bb-1 antibody neu-
tralizes parasite infectivity.
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